Roth Capital initiated coverage on Revelation Biosciences with a new price target

2/17/22 8:17:25 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Roth Capital initiated coverage of Revelation Biosciences with a rating of Buy and set a new price target of $12.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$REVB

Date	Price Target	Rating	Analyst
2/17/2022	$12.00	Buy	Roth Capital